Acusphere Inc
OTC:ACUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Acusphere Inc
Other Non-Cash Items
Acusphere Inc
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Acusphere Inc
OTC:ACUS
|
Other Non-Cash Items
$23.8m
|
CAGR 3-Years
86%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Non-Cash Items
$1.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Non-Cash Items
$4.5B
|
CAGR 3-Years
47%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
14%
|
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Non-Cash Items
$4.8B
|
CAGR 3-Years
68%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Non-Cash Items
$1B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-9%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Non-Cash Items
$4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Acusphere Inc
Glance View
Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).
See Also
What is Acusphere Inc's Other Non-Cash Items?
Other Non-Cash Items
23.8m
USD
Based on the financial report for Dec 31, 2008, Acusphere Inc's Other Non-Cash Items amounts to 23.8m USD.
What is Acusphere Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
57%
Over the last year, the Other Non-Cash Items growth was 586%. The average annual Other Non-Cash Items growth rates for Acusphere Inc have been 86% over the past three years , 57% over the past five years .
